Non-CME Educational Programs
Indicates that handouts are available

Thursday, March 1, 2018

These programs are not sponsored or programmed by the AAAAI/WAO.

6:30 PM-8:30 PM

 
The Impact of Shared Decision-Making on Patients with PIDD
Session Details
 
Thursday Non-CME Educational Program
Session Details

8:30 PM-10:30 PM

Friday, March 2, 2018

These programs are not sponsored or programmed by the AAAAI/WAO.

7:30 AM-9:30 AM

 
Friday Non-CME Educational Program
Session Details

6:30 PM-8:30 PM

 
Are Eosinophils a Key Component to Personalized Treatment?
Session Details
 
Clinical Issues in Atopic Dermatitis: Debates and Discussions About Managing Moderate-to-Severe Disease
Session Details
 
Expert Perspectives on Evolving Approaches in HAE Patient Management
Session Details

8:30 PM-10:30 PM

 
Managing Hereditary Angioedema with C1 Esterase Inhibitors (C1-INH)
Session Details

Saturday, March 3, 2018

These programs are not sponsored or programmed by the AAAAI/WAO.

6:00 AM-8:00 AM

 
Uncontrolled Asthma: The Role of Type 2 Inflammation
Session Details

6:30 PM-8:30 PM

 
DUPIXENT® (dupilumab) FDA-Approved
Session Details
 
Infant Anaphylaxis and a Newly FDA-Approved Treatment Option
Session Details
 
New Perspectives in the Treatment of Uncontrolled Allergic Asthma: A Case-Based Discussion
Session Details
 
Treating Adults with Uncontrolled Severe Eosinophilic Asthma (SEA)
Session Details

8:30 PM-10:30 PM

 

Sunday, March 4, 2018

These programs are not sponsored or programmed by the AAAAI/WAO.

6:00 AM-8:00 AM

 
Identifying Type 2 Inflammation in Asthma: Thinking Beyond Biomarkers 
Session Details

6:30 PM-8:30 PM

 
A Fresh Perspective on Severe Uncontrolled Asthma – A New Approach to Eosinophils
Session Details
 
Clinical Issues in Severe Asthma: Debates and Discussions About Personalizing Patient Management
Session Details
 
Looking Ahead: Exploring Clinical Developments in Peanut Allergy
Session Details
 
Uncontrolled Asthma—Expanding Your View of a Constricting Disease
Session Details

8:30 PM-10:30 PM

 
Defining Success for Patients: Individualizing Treatment for Primary Immunodeficiency
Session Details